Fig. 4From: Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational studyChange in caregiver time spent on instrumental activities of daily living (propensity score-adjusted). **p < 0.01; ***p < 0.001 for difference between study type at that time point; p = 0.0011 for overall difference between study type; p = 0.0023 for study type × visit interaction. EU EuropeanBack to article page